Literature DB >> 23966400

Processing of the VP1/2A junction is not necessary for production of foot-and-mouth disease virus empty capsids and infectious viruses: characterization of "self-tagged" particles.

Maria Gullberg1, Charlotta Polacek, Anette Bøtner, Graham J Belsham.   

Abstract

The foot-and-mouth disease virus (FMDV) capsid protein precursor, P1-2A, is cleaved by 3C(pro) to generate VP0, VP3, VP1, and the peptide 2A. The capsid proteins self-assemble into empty capsid particles or viruses which do not contain 2A. In a cell culture-adapted strain of FMDV (O1 Manisa [Lindholm]), three different amino acid substitutions (E83K, S134C, and K210E) were identified within the VP1 region of the P1-2A precursor compared to the field strain (wild type [wt]). Expression of the O1 Manisa P1-2A (wt or with the S134C substitution in VP1) plus 3C(pro), using a transient expression system, resulted in efficient capsid protein production and self-assembly of empty capsid particles. Removal of the 2A peptide from the capsid protein precursor had no effect on capsid protein processing or particle assembly. However, modification of E83K alone abrogated particle assembly with no apparent effect on protein processing. Interestingly, the K210E substitution, close to the VP1/2A junction, completely blocked processing by 3C(pro) at this cleavage site, but efficient assembly of "self-tagged" empty capsid particles, containing the uncleaved VP1-2A, was observed. These self-tagged particles behaved like the unmodified empty capsids in antigen enzyme-linked immunosorbent assays and integrin receptor binding assays. Furthermore, mutant viruses with uncleaved VP1-2A could be rescued in cells from full-length FMDV RNA transcripts encoding the K210E substitution in VP1. Thus, cleavage of the VP1/2A junction is not essential for virus viability. The production of such engineered self-tagged empty capsid particles may facilitate their purification for use as diagnostic reagents and vaccines.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23966400      PMCID: PMC3807367          DOI: 10.1128/JVI.01863-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

1.  Fine mapping of a foot-and-mouth disease virus epitope recognized by serotype-independent monoclonal antibody 4B2.

Authors:  Yongzhong Yu; Haiwei Wang; Lei Zhao; Chunyuan Zhang; Zhigang Jiang; Li Yu
Journal:  J Microbiol       Date:  2011-03-03       Impact factor: 3.422

2.  Insertion of type O-conserved neutralizing epitope into the foot-and-mouth disease virus type Asia1 VP1 G-H loop: effect on viral replication and neutralization phenotype.

Authors:  Haiwei Wang; Mei Xue; Decheng Yang; Guohui Zhou; Donglai Wu; Li Yu
Journal:  J Gen Virol       Date:  2012-04-18       Impact factor: 3.891

3.  Mapping of amino acid residues responsible for adhesion of cell culture-adapted foot-and-mouth disease SAT type viruses.

Authors:  Francois F Maree; Belinda Blignaut; Tjaart A P de Beer; Nico Visser; Elizabeth A Rieder
Journal:  Virus Res       Date:  2010-07-15       Impact factor: 3.303

4.  Foot-and-mouth disease virus (FMDV) with a stable FLAG epitope in the VP1 G-H loop as a new tool for studying FMDV pathogenesis.

Authors:  Paul Lawrence; Juan M Pacheco; Sabena Uddowla; Jason Hollister; Abhay Kotecha; Elizabeth Fry; Elizabeth Rieder
Journal:  Virology       Date:  2012-12-08       Impact factor: 3.616

5.  A dominant-negative mutant of rab5 inhibits infection of cells by foot-and-mouth disease virus: implications for virus entry.

Authors:  Helen L Johns; Stephen Berryman; Paul Monaghan; Graham J Belsham; Terry Jackson
Journal:  J Virol       Date:  2009-04-08       Impact factor: 5.103

6.  Foot-and-mouth disease virus assembly: processing of recombinant capsid precursor by exogenous protease induces self-assembly of pentamers in vitro in a myristoylation-dependent manner.

Authors:  Stewart Goodwin; Tobias J Tuthill; Armando Arias; Richard A Killington; David J Rowlands
Journal:  J Virol       Date:  2009-08-26       Impact factor: 5.103

7.  Low levels of foot-and-mouth disease virus 3C protease expression are required to achieve optimal capsid protein expression and processing in mammalian cells.

Authors:  Charlotta Polacek; Maria Gullberg; Jiong Li; Graham J Belsham
Journal:  J Gen Virol       Date:  2013-01-30       Impact factor: 3.891

8.  Capsid proteins from field strains of foot-and-mouth disease virus confer a pathogenic phenotype in cattle on an attenuated, cell-culture-adapted virus.

Authors:  Anette Bøtner; Naresh K Kakker; Cyril Barbezange; Stephen Berryman; Terry Jackson; Graham J Belsham
Journal:  J Gen Virol       Date:  2011-01-26       Impact factor: 3.891

9.  Rational engineering of recombinant picornavirus capsids to produce safe, protective vaccine antigen.

Authors:  Claudine Porta; Abhay Kotecha; Alison Burman; Terry Jackson; Jingshan Ren; Silvia Loureiro; Ian M Jones; Elizabeth E Fry; David I Stuart; Bryan Charleston
Journal:  PLoS Pathog       Date:  2013-03-27       Impact factor: 6.823

10.  Characterization of epitope-tagged foot-and-mouth disease virus.

Authors:  Julian Seago; Terry Jackson; Claudia Doel; Elizabeth Fry; David Stuart; Michiel M Harmsen; Bryan Charleston; Nicholas Juleff
Journal:  J Gen Virol       Date:  2012-07-18       Impact factor: 3.891

View more
  16 in total

Review 1.  Emergency Services of Viral RNAs: Repair and Remodeling.

Authors:  Vadim I Agol; Anatoly P Gmyl
Journal:  Microbiol Mol Biol Rev       Date:  2018-03-14       Impact factor: 11.056

2.  Modifications to the Foot-and-Mouth Disease Virus 2A Peptide: Influence on Polyprotein Processing and Virus Replication.

Authors:  Jonas Kjær; Graham J Belsham
Journal:  J Virol       Date:  2018-03-28       Impact factor: 5.103

3.  Selection of functional 2A sequences within foot-and-mouth disease virus; requirements for the NPGP motif with a distinct codon bias.

Authors:  Jonas Kjær; Graham J Belsham
Journal:  RNA       Date:  2017-10-17       Impact factor: 4.942

4.  Determinants of the VP1/2A junction cleavage by the 3C protease in foot-and-mouth disease virus-infected cells.

Authors:  Thea Kristensen; Preben Normann; Maria Gullberg; Ulrik Fahnøe; Charlotta Polacek; Thomas Bruun Rasmussen; Graham J Belsham
Journal:  J Gen Virol       Date:  2017-04-01       Impact factor: 3.891

Review 5.  Structures and Corresponding Functions of Five Types of Picornaviral 2A Proteins.

Authors:  Xiaoyao Yang; Anchun Cheng; Mingshu Wang; Renyong Jia; Kunfeng Sun; Kangcheng Pan; Qiao Yang; Ying Wu; Dekang Zhu; Shun Chen; Mafeng Liu; Xin-Xin Zhao; Xiaoyue Chen
Journal:  Front Microbiol       Date:  2017-07-21       Impact factor: 5.640

6.  DHAV-1 2A1 Peptide - A Newly Discovered Co-expression Tool That Mediates the Ribosomal "Skipping" Function.

Authors:  Xiaoyao Yang; Qiurui Zeng; Mingshu Wang; Anchun Cheng; Kangcheng Pan; Dekang Zhu; Mafeng Liu; Renyong Jia; Qiao Yang; Ying Wu; Shun Chen; Xinxin Zhao; Shaqiu Zhang; Yunya Liu; Yanling Yu; Ling Zhang
Journal:  Front Microbiol       Date:  2018-11-15       Impact factor: 5.640

7.  Identification of a short, highly conserved, motif required for picornavirus capsid precursor processing at distal sites.

Authors:  Thea Kristensen; Graham J Belsham
Journal:  PLoS Pathog       Date:  2019-01-18       Impact factor: 6.823

8.  A Prime-Boost Vaccination Strategy in Cattle to Prevent Foot-and-Mouth Disease Using a "Single-Cycle" Alphavirus Vector and Empty Capsid Particles.

Authors:  Maria Gullberg; Louise Lohse; Anette Bøtner; Gerald M McInerney; Alison Burman; Terry Jackson; Charlotta Polacek; Graham J Belsham
Journal:  PLoS One       Date:  2016-06-13       Impact factor: 3.240

9.  Influence of cell type and cell culture media on the propagation of foot-and-mouth disease virus with regard to vaccine quality.

Authors:  Veronika Dill; Bernd Hoffmann; Aline Zimmer; Martin Beer; Michael Eschbaumer
Journal:  Virol J       Date:  2018-03-16       Impact factor: 4.099

10.  The Cellular Chaperone Heat Shock Protein 90 Is Required for Foot-and-Mouth Disease Virus Capsid Precursor Processing and Assembly of Capsid Pentamers.

Authors:  Joseph Newman; Amin S Asfor; Stephen Berryman; Terry Jackson; Stephen Curry; Tobias J Tuthill
Journal:  J Virol       Date:  2018-02-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.